Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Acetaminophen × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 5 Pain, Postoperative 3 Lung Neoplasms 3 Agnosia 3 Colonic Neoplasms 2 Cancer Pain 2 Acute Pain 2 Trigger Finger Disorder 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Skin Neoplasms 1 Rectal Neoplasms 1 Patient Satisfaction 1 Parathyroid Neoplasms 1 Parathyroid Diseases 1 Opioid-Related Disorders 1 Neoplasms 1 Multiple Myeloma 1 Menorrhagia 1 Median Neuropathy 1 Leiomyoma 1 Ileus 1 Hemorrhage 1 Goiter 1 Ganglion Cysts 1 Fever 1 Emergence Delirium 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1

Interventions

Letrozole 18 exemestane 11 Docetaxel 11 Anastrozole 11 Tamoxifen 9 Cyclophosphamide 9 Capecitabine 9 Zoledronic Acid 8 Paclitaxel 8 pegfilgrastim 7 Trastuzumab 7 Fulvestrant 7 Saline Solution 6 liposomal doxorubicin 5 Sodium Chloride 5 Epirubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 palbociclib 4 abemaciclib 4 Tranexamic Acid 4 Filgrastim 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 pegylated granulocyte colony-stimulating factor 3 eribulin 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡